Medtech flat at Bristol-Myers
This article was originally published in Clinica
Executive Summary
Medical device sales are failing to show much buoyancy at Bristol-Myers Squibb. In the first quarter, they fell 1% which, adjusted for unfavourable exchange rate moves, would have been a 2% increase. This follows a similar trend in 1996 when medical device sales declined 2% to $1,860 million (see Clinica No 741, p 11).